Skip to content

To Evaluate the efficacy of Amritadi Kwath in the management of Mutrakricchra with special reference to urinary tract infection

A Randomized open- label controlled clinical study to evaluate the efficacy of Amritadi Kwath in the management of Mutrakricchra with special reference to urinary tract infection - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080465
Enrollment
30
Registered
2025-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system Health Condition 2: N30-N39- Other diseases of the urinary system

Interventions

None listed

Sponsors

Jammu institute of ayurveda and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient representing sings and symptoms of mutrakricchra will be willing to participate in study. subject willing to participate with written consent which will be conveyed in the language that the participant can understand.

Exclusion criteria

Exclusion criteria: patient suffering from diabetes mellitus, diabetes insipidus, pyelonephritis, uncontrolled hypertension, tuberculosis, renal disease, anatomical deformity, thyroid dysfunction, pelvic neoplasm, surgical history (phimosis), renal calculi, benign prostatic hyperplasia.

Design outcomes

Primary

MeasureTime frame
Sadaham mutra, Sarujam mutra, Muhurmuhur mutraTimepoint: Baseline

Secondary

MeasureTime frame
Changes in mutrakriccha(UTI) grading score.Timepoint: Baseline,30th,45th day

Countries

India

Contacts

Public ContactDr Nitin Mahajan

Jammu institute of ayurveda and research

drnitinmahajan1608@gmail.com9419119123

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026